Dunn School of Pathology, University of Oxford Immunological barriers to cell replacement therapy in animal models and prospects for the induction of immunological tolerance ______________________________
55-63 Petersen C, Kuske M, Bruns E, Biermanns D, Wussow PV, Mildenberger H: Progress in developing animal models for biliary atresia. Eur J Pediatr Surg 1998; 8(3): 137-41 Ridder GJ, Maschek H, Flemming
(Funding: BMBF) Functional liver cells from induced pluripotent stem cells as an alternative to animal experiments in the Institute of Toxicology (Funding: R2N network, MWK Lower Saxony) CONSENSE-T -
Steffens S, Terracciano CM, Tocchetti CG, Vlasman P, Yeung KK, Zacchigna S, Zwaagman D, Thum T. Animal models and animal-free innovations for cardiovascular research: Current status and routes to be explored.
(IDOH) Human - Animal - Environment Here you will learn the basics of various infectious diseases with special reference to zoonotic pathogens, i.e. pathogens that can jump from animals to humans. ⇒ about
small part of a balanced and healthy diet, keyword "plant-based diet". Compared to a diet with more animal-based foods, a plant-based diet scores points with fewer saturated fatty acids and cholesterol as
capacity. 4. the prototypes are analyzed in so-called phantom circuits as well as in large and small animal experiments with regard to their biological compatibility, their gas exchange capacity and the f
coupling of myofibrils Investigations of human, human pluripotent stem cell-derived cardiomyocytes and animal contractile models in non-pathologic and pathologic conditions Forschungsschwerpunkt Contraction
protection. Please find the publication here: https: //pubmed.ncbi.nlm.nih.gov/35077859/ Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. [...] proven its value in providing preclinical evidence of efficacy and should help to significantly reduce animal testing in the future. "The tests in the cultivation chambers have shown that the miR-21 blocker [...] treatment of heart failure, and diverse aspects in translational cardiovascular medicine, including large animal and early clinical trial studies. MHH funds the beginning of two innovative projects January 2023
ston 2003; pp. 48-55 Gunzer F, Hennig-Pauka I, Waldmann KH, Mengel M : Gnotobiotic piglets as an animal model for oral infection with O157 and non-O157 serotypes of STEC. In: Methods in Molecular Medicine